Search
for
Sort by
Research 211–240 of 1000+
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Dermatological Manifestations of COVID-19: A Comprehensive Review
- Upper gastrointestinal bleeding during the COVID-19 pandemic; particularities of diagnosis and therapy
- Hormones and COVID-19
- Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Rare and common manifestations of COVID‐19 in children
- Online search interest in long-term symptoms of coronavirus disease 2019 during the COVID-19 pandemic in Japan: Infodemiology study using the most visited search engine in Japan
- FEATURES OF DIAGNOSIS OF POSTCOVID ALOPECIA
- Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
- Dermatology practice in a high-tech world
- Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients
- EVALUATION OF ASSOCIATION OF ANTHROPOMETRIC INDICES WITH STRESS RESPONSE IN PCOS POPULATION
- APPROACHING ALOPECIA TREATMENT VIA POLYMERIC NANOPARTICLES: A BRIEF OVERVIEW
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- A Comment on Coronavirus Disease 2019 and the Hair
- The Role of Vitamin D and Testosterone Levels with Hair Loss among Females with Coronavirus Disease
- Hair loss after SARS-CoV2 Infection
- Regenerative potential and clinical application of mesenchymal stem cell-derived exosomes (review)
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Plasma Therapy Gains Attention in Treatment of Viral Infections, Dermatological Illness, and Orthopedic Illnesses
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Patient‐reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
- The significance of coronavirus infection in the development of reproductive and lower urinary tract lesions
- Factors influencing alopecia areata treatment decisions: A qualitative assessment
- New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching
- JCD — Editorial Commentary, May, 2021
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)